Items where authors include "Horgan, C."

Article

Sanchez-Guijo, F. orcid.org/0000-0002-7076-7739, Vives, J. orcid.org/0000-0001-9719-5235, Ruggeri, A. et al. (15 more authors) (2024) Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT). Cytotherapy. ISSN 1465-3249

Kaparou, M., Rudzki, Z., Giles, H. et al. (16 more authors) (2021) Management of allogeneic stem cell transplantation for high-risk AML following SARS-CoV-2 associated pancytopenia with marked bone marrow biopsy alterations. Case Reports in Hematology, 2021. 8843063. ISSN 2090-6560

Kanellopoulos, A. orcid.org/0000-0002-7400-5416, Ahmed, M.Z., Kishore, B. et al. (15 more authors) (2020) COVID‐19 in bone marrow transplant recipients : reflecting on a single centre experience. British Journal of Haematology, 190 (2). e67-e70. ISSN 0007-1048

Horgan, C., Kartsios, C., Nikolousis, E. et al. (13 more authors) (2020) First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation. Leukemia Research Reports, 14. 100213. ISSN 2213-0489

McIlroy, G., Nikolousis, E., Abou-Zeid, N. et al. (9 more authors) (2020) Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation. Leukemia & Lymphoma, 61 (1). pp. 202-205. ISSN 1042-8194

Lloyd, R., Nikolousis, E., Kishore, B. et al. (11 more authors) (2020) Autoimmune cytopenias developing late post alemtuzumab-based allogeneic stem cell transplantation: presentation of short case series from a transplant center. Cell Transplantation, 29. ISSN 0963-6897

Horgan, C., Elmoamly, S., McIlroy, G. et al. (9 more authors) (2019) Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma : reflections on a single center experience. Leukemia & Lymphoma, 60 (12). pp. 3075-3077. ISSN 1042-8194

Horgan, C., Kanellopoulos, A., Paneesha, S. et al. (3 more authors) (2019) A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant. Hematology Reports, 11 (1). 7800. ISSN 2038-8322